New generic asthma inhaler put to the test in major trial
Disease control
Not yet recruiting
This study aims to see if a new, more affordable generic version of a common asthma inhaler works just as well and is as safe as the original brand-name product. It will involve about 1,430 adults with asthma who will use one of the inhalers or a placebo (dummy treatment) for fou…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC